Investigating the effects of co-treatment of type one interferons and granulocyte colony-stimulating factor on Glucose, triglycerides and cholesterol of blood serum in Syrian mouse

Background and granulocyte colony-stimulating factor (G-CSF) has a major role in blood cells differentiation especially in neutrophils, therefore G-CSF widely has been used in treatment of chemotherapy-induced neutropenia. Different lines of evidence indicated that G-CSF is increased in inflammatory situation and has inflammatory characteristics. Unlike G-CSF, type I interferones (IFNs) have been shown to have anti-inflammatory effects. The aim of this study was to investigate whether type I IFNs can normalize the effects of G-CSF on blood factors.
forty-two mice (male, eight weeks) were divided into six groups of seven, which includes Group 1 (control) injection of distilled water, Group 2 injection 200 µg/kg b.w. G-CSF, Group 3 injection 200 µg/kg b.w. Alfa interferon (IFN-α), Group 4 injection 200 µg/kg b.w. interferon beta (IFN-β), Group 5 injection 200 µg/kg b.w. G-CSF� µg/kg b.w. IFN-α, Group 6 injection 200 µg/kg b.w. G-CSF� µg/kg b.w. IFN-β. After 28 days, blood was taken from each mouse heart and blood biochemical parameters (Glucose, Triglyceride, Cholestrol) was investigated.
surprisingly, in most cases, the G-CSF and type one IFNs alone or simultaneously reduced the levels of Glucose, triglycerides and cholesterol. Also the reduction of glucose, triglycerides and cholesterol were higher in G-CSF and INFs in compare with G-CSF alone. Our data raise the possibility that, G-CSF and INF-α/β have some similarity in signaling pathway which has to be investigated.